November 01, 2018
For Immediate Release
The Centers for Medicare and Medicaid Services (CMS) awarded seven organizations funding to develop, improve, update, and expand quality measures for Medicare’s Quality Payment Program (QPP).
IMPAQ International, in partnership with our prime The American Society of Clinical Pathology (ASCP), was awarded one of the seven multimillion-dollar grants from CMS to provide strategic, technical, and performance measurement support specific to the development and implementation of pathology measures to fill critical measurement gap areas that can be reported using the National Pathology Clinical Registry (NPQR), a key tool that helps laboratories optimize quality and performance.
“The Quality Payment Program, by its very nature, is intended to transform clinician reimbursement by rewarding quality over quantity of care,” said Mike Sacca, Managing Director for IMPAQ Health. “As IMPAQ is now assisting CMS with all areas of the program, we are thrilled to be helping usher in the era of value-based health care payments.”
This cooperative agreement, authorized under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), represents the first funding initiative supporting public-private efforts to develop measures for the QPP. Entering its third year in 2019, the QPP consists of two participation pathways for doctors and other clinicians: the Merit-based Incentive Payment System (MIPS), which measures performance in four categories to determine an adjustment to Medicare payment, and Advanced Alternative Payment Models (APMs), in which clinicians may earn an incentive payment through sufficient participation in risk-based payment models.
In addition to working with the ASCP, IMPAQ’s previous partnerships with the American Psychiatric Association (APA) and the American Academy of Hospice and Palliative Medicine (AAHPM) contributed to CMS awarding additional cooperative agreement awards to these two prominent medical societies. IMPAQ assisted with the strategy, development, and implementation of registries for the APA and AAHPM, registries that will now be utilized in their respective QPP grants.
IMPAQ and ASCP are excited to work closely with CMS to develop and implement pathology measures that offer the most promise for improving patient care.
About IMPAQ International
IMPAQ evaluates and enhances the policies, programs, and products of public and private sector organizations. We drive value with innovative thinking and rigorous approaches that deliver meaningful insight and real world impact. Learn more at www.impaqint.com.